id	sid	tid	token	lemma	pos
cord-266948-n7sltd1b	1	1	key	key	JJ
cord-266948-n7sltd1b	2	1	:	:	:
cord-266948-n7sltd1b	2	2	cord-266948-n7sltd1b	cord-266948-n7sltd1b	NNP
cord-266948-n7sltd1b	2	3	authors	author	NNS
cord-266948-n7sltd1b	2	4	:	:	:
cord-266948-n7sltd1b	2	5	Ahamed	Ahamed	NNP
cord-266948-n7sltd1b	2	6	,	,	,
cord-266948-n7sltd1b	2	7	Jasimuddin	Jasimuddin	NNP
cord-266948-n7sltd1b	2	8	title	title	NN
cord-266948-n7sltd1b	2	9	:	:	:
cord-266948-n7sltd1b	3	1	Severe	severe	JJ
cord-266948-n7sltd1b	3	2	aortic	aortic	JJ
cord-266948-n7sltd1b	3	3	stenosis	stenosis	NN
cord-266948-n7sltd1b	3	4	patient	patient	NN
cord-266948-n7sltd1b	3	5	risk	risk	NN
cord-266948-n7sltd1b	3	6	during	during	IN
cord-266948-n7sltd1b	3	7	the	the	DT
cord-266948-n7sltd1b	3	8	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	3	9	pandemic	pandemic	NN
cord-266948-n7sltd1b	3	10	date	date	NN
cord-266948-n7sltd1b	3	11	:	:	:
cord-266948-n7sltd1b	3	12	2020	2020	CD
cord-266948-n7sltd1b	3	13	-	-	HYPH
cord-266948-n7sltd1b	3	14	09	09	CD
cord-266948-n7sltd1b	3	15	-	-	SYM
cord-266948-n7sltd1b	3	16	14	14	CD
cord-266948-n7sltd1b	3	17	journal	journal	NN
cord-266948-n7sltd1b	3	18	:	:	:
cord-266948-n7sltd1b	4	1	Open	open	JJ
cord-266948-n7sltd1b	4	2	Heart	heart	NN
cord-266948-n7sltd1b	4	3	DOI	doi	NN
cord-266948-n7sltd1b	4	4	:	:	:
cord-266948-n7sltd1b	5	1	10.1136	10.1136	CD
cord-266948-n7sltd1b	5	2	/	/	SYM
cord-266948-n7sltd1b	5	3	openhrt-2020	openhrt-2020	NN
cord-266948-n7sltd1b	5	4	-	-	HYPH
cord-266948-n7sltd1b	5	5	001355	001355	CD
cord-266948-n7sltd1b	5	6	sha	sha	NNP
cord-266948-n7sltd1b	5	7	:	:	:
cord-266948-n7sltd1b	5	8	bcfb88f6e5fa21c64d32c6b0a9960e5d58e5b240	bcfb88f6e5fa21c64d32c6b0a9960e5d58e5b240	ADD
cord-266948-n7sltd1b	5	9	doc_id	doc_id	CD
cord-266948-n7sltd1b	5	10	:	:	:
cord-266948-n7sltd1b	5	11	266948	266948	CD
cord-266948-n7sltd1b	5	12	cord_uid	cord_uid	NNS
cord-266948-n7sltd1b	5	13	:	:	:
cord-266948-n7sltd1b	6	1	n7sltd1b	n7sltd1b	NNP
cord-266948-n7sltd1b	7	1	nan	nan	NNP
cord-266948-n7sltd1b	7	2	SARS	SARS	NNP
cord-266948-n7sltd1b	7	3	-	-	HYPH
cord-266948-n7sltd1b	7	4	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	7	5	infection	infection	NN
cord-266948-n7sltd1b	7	6	can	can	MD
cord-266948-n7sltd1b	7	7	be	be	VB
cord-266948-n7sltd1b	7	8	an	an	DT
cord-266948-n7sltd1b	7	9	additional	additional	JJ
cord-266948-n7sltd1b	7	10	and	and	CC
cord-266948-n7sltd1b	7	11	very	very	RB
cord-266948-n7sltd1b	7	12	dangerous	dangerous	JJ
cord-266948-n7sltd1b	7	13	comorbidity	comorbidity	NN
cord-266948-n7sltd1b	7	14	.	.	.
cord-266948-n7sltd1b	8	1	Therefore	therefore	RB
cord-266948-n7sltd1b	8	2	,	,	,
cord-266948-n7sltd1b	8	3	I	-PRON-	PRP
cord-266948-n7sltd1b	8	4	suggest	suggest	VBP
cord-266948-n7sltd1b	8	5	that	that	IN
cord-266948-n7sltd1b	8	6	the	the	DT
cord-266948-n7sltd1b	8	7	following	follow	VBG
cord-266948-n7sltd1b	8	8	points	point	NNS
cord-266948-n7sltd1b	8	9	should	should	MD
cord-266948-n7sltd1b	8	10	be	be	VB
cord-266948-n7sltd1b	8	11	considered	consider	VBN
cord-266948-n7sltd1b	8	12	:	:	:
cord-266948-n7sltd1b	9	1	1	1	LS
cord-266948-n7sltd1b	9	2	.	.	.
cord-266948-n7sltd1b	10	1	Low	low	JJ
cord-266948-n7sltd1b	10	2	-	-	HYPH
cord-266948-n7sltd1b	10	3	risk	risk	NN
cord-266948-n7sltd1b	10	4	,	,	,
cord-266948-n7sltd1b	10	5	asymptomatic	asymptomatic	JJ
cord-266948-n7sltd1b	10	6	patients	patient	NNS
cord-266948-n7sltd1b	10	7	who	who	WP
cord-266948-n7sltd1b	10	8	can	can	MD
cord-266948-n7sltd1b	10	9	delay	delay	VB
cord-266948-n7sltd1b	10	10	their	-PRON-	PRP$
cord-266948-n7sltd1b	10	11	procedures	procedure	NNS
cord-266948-n7sltd1b	10	12	must	must	MD
cord-266948-n7sltd1b	10	13	stringently	stringently	RB
cord-266948-n7sltd1b	10	14	avoid	avoid	VB
cord-266948-n7sltd1b	10	15	infection	infection	NN
cord-266948-n7sltd1b	10	16	,	,	,
cord-266948-n7sltd1b	10	17	for	for	IN
cord-266948-n7sltd1b	10	18	instance	instance	NN
cord-266948-n7sltd1b	10	19	by	by	IN
cord-266948-n7sltd1b	10	20	following	follow	VBG
cord-266948-n7sltd1b	10	21	guidelines	guideline	NNS
cord-266948-n7sltd1b	10	22	for	for	IN
cord-266948-n7sltd1b	10	23	hygiene	hygiene	NN
cord-266948-n7sltd1b	10	24	and	and	CC
cord-266948-n7sltd1b	10	25	wearing	wear	VBG
cord-266948-n7sltd1b	10	26	masks	mask	NNS
cord-266948-n7sltd1b	10	27	,	,	,
cord-266948-n7sltd1b	10	28	and	and	CC
cord-266948-n7sltd1b	10	29	should	should	MD
cord-266948-n7sltd1b	10	30	continue	continue	VB
cord-266948-n7sltd1b	10	31	to	to	TO
cord-266948-n7sltd1b	10	32	maintain	maintain	VB
cord-266948-n7sltd1b	10	33	strength	strength	NN
cord-266948-n7sltd1b	10	34	and	and	CC
cord-266948-n7sltd1b	10	35	endurance	endurance	NN
cord-266948-n7sltd1b	10	36	as	as	RB
cord-266948-n7sltd1b	10	37	much	much	RB
cord-266948-n7sltd1b	10	38	as	as	IN
cord-266948-n7sltd1b	10	39	possible	possible	JJ
cord-266948-n7sltd1b	10	40	by	by	IN
cord-266948-n7sltd1b	10	41	routine	routine	JJ
cord-266948-n7sltd1b	10	42	exercise	exercise	NN
cord-266948-n7sltd1b	10	43	.	.	.
cord-266948-n7sltd1b	11	1	should	should	MD
cord-266948-n7sltd1b	11	2	discuss	discuss	VB
cord-266948-n7sltd1b	11	3	the	the	DT
cord-266948-n7sltd1b	11	4	potential	potential	JJ
cord-266948-n7sltd1b	11	5	benefits	benefit	NNS
cord-266948-n7sltd1b	11	6	and	and	CC
cord-266948-n7sltd1b	11	7	risks	risk	NNS
cord-266948-n7sltd1b	11	8	,	,	,
cord-266948-n7sltd1b	11	9	including	include	VBG
cord-266948-n7sltd1b	11	10	the	the	DT
cord-266948-n7sltd1b	11	11	new	new	JJ
cord-266948-n7sltd1b	11	12	risk	risk	NN
cord-266948-n7sltd1b	11	13	of	of	IN
cord-266948-n7sltd1b	11	14	comorbidities	comorbiditie	NNS
cord-266948-n7sltd1b	11	15	with	with	IN
cord-266948-n7sltd1b	11	16	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	11	17	that	that	WDT
cord-266948-n7sltd1b	11	18	can	can	MD
cord-266948-n7sltd1b	11	19	be	be	VB
cord-266948-n7sltd1b	11	20	life	life	NN
cord-266948-n7sltd1b	11	21	threatening	threaten	VBG
cord-266948-n7sltd1b	11	22	,	,	,
cord-266948-n7sltd1b	11	23	of	of	IN
cord-266948-n7sltd1b	11	24	hospitalisation	hospitalisation	NN
cord-266948-n7sltd1b	11	25	with	with	IN
cord-266948-n7sltd1b	11	26	their	-PRON-	PRP$
cord-266948-n7sltd1b	11	27	cardiologists	cardiologist	NNS
cord-266948-n7sltd1b	11	28	.	.	.
cord-266948-n7sltd1b	12	1	Therefore	therefore	RB
cord-266948-n7sltd1b	12	2	,	,	,
cord-266948-n7sltd1b	12	3	physicians	physician	NNS
cord-266948-n7sltd1b	12	4	should	should	MD
cord-266948-n7sltd1b	12	5	have	have	VB
cord-266948-n7sltd1b	12	6	all	all	DT
cord-266948-n7sltd1b	12	7	pertinent	pertinent	JJ
cord-266948-n7sltd1b	12	8	information	information	NN
cord-266948-n7sltd1b	12	9	to	to	TO
cord-266948-n7sltd1b	12	10	identify	identify	VB
cord-266948-n7sltd1b	12	11	the	the	DT
cord-266948-n7sltd1b	12	12	appropriate	appropriate	JJ
cord-266948-n7sltd1b	12	13	procedure	procedure	NN
cord-266948-n7sltd1b	12	14	,	,	,
cord-266948-n7sltd1b	12	15	considering	consider	VBG
cord-266948-n7sltd1b	12	16	both	both	CC
cord-266948-n7sltd1b	12	17	AVR	AVR	NNP
cord-266948-n7sltd1b	12	18	and	and	CC
cord-266948-n7sltd1b	12	19	TAVR	TAVR	NNP
cord-266948-n7sltd1b	12	20	approaches	approach	NNS
cord-266948-n7sltd1b	12	21	.	.	.
cord-266948-n7sltd1b	13	1	The	the	DT
cord-266948-n7sltd1b	13	2	patient	patient	JJ
cord-266948-n7sltd1b	13	3	risk	risk	NN
cord-266948-n7sltd1b	13	4	assessment	assessment	NN
cord-266948-n7sltd1b	13	5	typically	typically	RB
cord-266948-n7sltd1b	13	6	includes	include	VBZ
cord-266948-n7sltd1b	13	7	patient	patient	JJ
cord-266948-n7sltd1b	13	8	age	age	NN
cord-266948-n7sltd1b	13	9	and	and	CC
cord-266948-n7sltd1b	13	10	surgical	surgical	JJ
cord-266948-n7sltd1b	13	11	risk	risk	NN
cord-266948-n7sltd1b	13	12	;	;	:
cord-266948-n7sltd1b	13	13	however	however	RB
cord-266948-n7sltd1b	13	14	,	,	,
cord-266948-n7sltd1b	13	15	given	give	VBN
cord-266948-n7sltd1b	13	16	the	the	DT
cord-266948-n7sltd1b	13	17	increased	increase	VBN
cord-266948-n7sltd1b	13	18	general	general	JJ
cord-266948-n7sltd1b	13	19	risk	risk	NN
cord-266948-n7sltd1b	13	20	of	of	IN
cord-266948-n7sltd1b	13	21	the	the	DT
cord-266948-n7sltd1b	13	22	procedure	procedure	NN
cord-266948-n7sltd1b	13	23	and	and	CC
cord-266948-n7sltd1b	13	24	that	that	IN
cord-266948-n7sltd1b	13	25	SARS	SARS	NNP
cord-266948-n7sltd1b	13	26	-	-	HYPH
cord-266948-n7sltd1b	13	27	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	13	28	infection	infection	NN
cord-266948-n7sltd1b	13	29	can	can	MD
cord-266948-n7sltd1b	13	30	be	be	VB
cord-266948-n7sltd1b	13	31	an	an	DT
cord-266948-n7sltd1b	13	32	additional	additional	JJ
cord-266948-n7sltd1b	13	33	and	and	CC
cord-266948-n7sltd1b	13	34	very	very	RB
cord-266948-n7sltd1b	13	35	dangerous	dangerous	JJ
cord-266948-n7sltd1b	13	36	comorbidity	comorbidity	NN
cord-266948-n7sltd1b	13	37	,	,	,
cord-266948-n7sltd1b	13	38	suggesting	suggest	VBG
cord-266948-n7sltd1b	13	39	the	the	DT
cord-266948-n7sltd1b	13	40	less	less	RBR
cord-266948-n7sltd1b	13	41	invasive	invasive	JJ
cord-266948-n7sltd1b	13	42	TAVR	TAVR	NNP
cord-266948-n7sltd1b	13	43	should	should	MD
cord-266948-n7sltd1b	13	44	be	be	VB
cord-266948-n7sltd1b	13	45	considered	consider	VBN
cord-266948-n7sltd1b	13	46	.	.	.
cord-266948-n7sltd1b	14	1	3	3	LS
cord-266948-n7sltd1b	14	2	.	.	.
cord-266948-n7sltd1b	15	1	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	15	2	may	may	MD
cord-266948-n7sltd1b	15	3	predispose	predispose	VB
cord-266948-n7sltd1b	15	4	some	some	DT
cord-266948-n7sltd1b	15	5	patients	patient	NNS
cord-266948-n7sltd1b	15	6	to	to	IN
cord-266948-n7sltd1b	15	7	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	15	8	,	,	,
cord-266948-n7sltd1b	15	9	and	and	CC
cord-266948-n7sltd1b	15	10	there	there	EX
cord-266948-n7sltd1b	15	11	are	be	VBP
cord-266948-n7sltd1b	15	12	instances	instance	NNS
cord-266948-n7sltd1b	15	13	in	in	IN
cord-266948-n7sltd1b	15	14	which	which	WDT
cord-266948-n7sltd1b	15	15	standard	standard	JJ
cord-266948-n7sltd1b	15	16	heparin	heparin	NN
cord-266948-n7sltd1b	15	17	-	-	HYPH
cord-266948-n7sltd1b	15	18	based	base	VBN
cord-266948-n7sltd1b	15	19	anticoagulants	anticoagulant	NNS
cord-266948-n7sltd1b	15	20	,	,	,
cord-266948-n7sltd1b	15	21	even	even	RB
cord-266948-n7sltd1b	15	22	at	at	IN
cord-266948-n7sltd1b	15	23	full	full	JJ
cord-266948-n7sltd1b	15	24	dosage	dosage	NN
cord-266948-n7sltd1b	15	25	,	,	,
cord-266948-n7sltd1b	15	26	are	be	VBP
cord-266948-n7sltd1b	15	27	ineffective	ineffective	JJ
cord-266948-n7sltd1b	15	28	in	in	IN
cord-266948-n7sltd1b	15	29	preventing	prevent	VBG
cord-266948-n7sltd1b	15	30	ongoing	ongoing	JJ
cord-266948-n7sltd1b	15	31	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	15	32	.	.	.
cord-266948-n7sltd1b	16	1	5	5	LS
cord-266948-n7sltd1b	17	1	AS	as	IN
cord-266948-n7sltd1b	17	2	patients	patient	NNS
cord-266948-n7sltd1b	17	3	therefore	therefore	RB
cord-266948-n7sltd1b	17	4	may	may	MD
cord-266948-n7sltd1b	17	5	have	have	VB
cord-266948-n7sltd1b	17	6	increased	increase	VBN
cord-266948-n7sltd1b	17	7	risk	risk	NN
cord-266948-n7sltd1b	17	8	for	for	IN
cord-266948-n7sltd1b	17	9	developing	develop	VBG
cord-266948-n7sltd1b	17	10	thromboembolic	thromboembolic	JJ
cord-266948-n7sltd1b	17	11	complications	complication	NNS
cord-266948-n7sltd1b	17	12	during	during	IN
cord-266948-n7sltd1b	17	13	the	the	DT
cord-266948-n7sltd1b	17	14	valve	valve	NN
cord-266948-n7sltd1b	17	15	replacement	replacement	NN
cord-266948-n7sltd1b	17	16	procedure	procedure	NN
cord-266948-n7sltd1b	17	17	or	or	CC
cord-266948-n7sltd1b	17	18	during	during	IN
cord-266948-n7sltd1b	17	19	subsequent	subsequent	JJ
cord-266948-n7sltd1b	17	20	hospitalisation	hospitalisation	NN
cord-266948-n7sltd1b	17	21	and	and	CC
cord-266948-n7sltd1b	17	22	recovery	recovery	NN
cord-266948-n7sltd1b	17	23	if	if	IN
cord-266948-n7sltd1b	17	24	they	-PRON-	PRP
cord-266948-n7sltd1b	17	25	are	be	VBP
cord-266948-n7sltd1b	17	26	infected	infect	VBN
cord-266948-n7sltd1b	17	27	with	with	IN
cord-266948-n7sltd1b	17	28	SARS	SARS	NNP
cord-266948-n7sltd1b	17	29	-	-	HYPH
cord-266948-n7sltd1b	17	30	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	17	31	.	.	.
cord-266948-n7sltd1b	18	1	Although	although	IN
cord-266948-n7sltd1b	18	2	most	most	JJS
cord-266948-n7sltd1b	18	3	patients	patient	NNS
cord-266948-n7sltd1b	18	4	with	with	IN
cord-266948-n7sltd1b	18	5	severe	severe	JJ
cord-266948-n7sltd1b	18	6	COVID-19	covid-19	NN
cord-266948-n7sltd1b	18	7	who	who	WP
cord-266948-n7sltd1b	18	8	develop	develop	VBP
cord-266948-n7sltd1b	18	9	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	18	10	develop	develop	VBP
cord-266948-n7sltd1b	18	11	venous	venous	JJ
cord-266948-n7sltd1b	18	12	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	18	13	,	,	,
cord-266948-n7sltd1b	18	14	some	some	DT
cord-266948-n7sltd1b	18	15	also	also	RB
cord-266948-n7sltd1b	18	16	develop	develop	VBP
cord-266948-n7sltd1b	18	17	arterial	arterial	JJ
cord-266948-n7sltd1b	18	18	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	18	19	.	.	.
cord-266948-n7sltd1b	19	1	In	in	IN
cord-266948-n7sltd1b	19	2	fact	fact	NN
cord-266948-n7sltd1b	19	3	,	,	,
cord-266948-n7sltd1b	19	4	a	a	DT
cord-266948-n7sltd1b	19	5	recent	recent	JJ
cord-266948-n7sltd1b	19	6	study	study	NN
cord-266948-n7sltd1b	19	7	showed	show	VBD
cord-266948-n7sltd1b	19	8	that	that	IN
cord-266948-n7sltd1b	19	9	a	a	DT
cord-266948-n7sltd1b	19	10	prosthetic	prosthetic	JJ
cord-266948-n7sltd1b	19	11	aortic	aortic	JJ
cord-266948-n7sltd1b	19	12	graft	graft	NN
cord-266948-n7sltd1b	19	13	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	19	14	patient	patient	NN
cord-266948-n7sltd1b	19	15	died	die	VBD
cord-266948-n7sltd1b	19	16	from	from	IN
cord-266948-n7sltd1b	19	17	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	19	18	and	and	CC
cord-266948-n7sltd1b	19	19	that	that	IN
cord-266948-n7sltd1b	19	20	anticoagulant	anticoagulant	NN
cord-266948-n7sltd1b	19	21	and	and	CC
cord-266948-n7sltd1b	19	22	thrombectomy	thrombectomy	NN
cord-266948-n7sltd1b	19	23	procedure	procedure	NN
cord-266948-n7sltd1b	19	24	were	be	VBD
cord-266948-n7sltd1b	19	25	unsuccessful	unsuccessful	JJ
cord-266948-n7sltd1b	19	26	.	.	.
cord-266948-n7sltd1b	20	1	6	6	CD
cord-266948-n7sltd1b	21	1	Therefore	therefore	RB
cord-266948-n7sltd1b	21	2	,	,	,
cord-266948-n7sltd1b	21	3	the	the	DT
cord-266948-n7sltd1b	21	4	risk	risk	NN
cord-266948-n7sltd1b	21	5	of	of	IN
cord-266948-n7sltd1b	21	6	prosthetic	prosthetic	JJ
cord-266948-n7sltd1b	21	7	valve	valve	NN
cord-266948-n7sltd1b	21	8	implantation	implantation	NN
cord-266948-n7sltd1b	21	9	should	should	MD
cord-266948-n7sltd1b	21	10	be	be	VB
cord-266948-n7sltd1b	21	11	seriously	seriously	RB
cord-266948-n7sltd1b	21	12	considered	consider	VBN
cord-266948-n7sltd1b	21	13	.	.	.
cord-266948-n7sltd1b	22	1	If	if	IN
cord-266948-n7sltd1b	22	2	this	this	DT
cord-266948-n7sltd1b	22	3	pro	pro	JJ
cord-266948-n7sltd1b	22	4	-	-	JJ
cord-266948-n7sltd1b	22	5	cedure	cedure	JJ
cord-266948-n7sltd1b	22	6	is	be	VBZ
cord-266948-n7sltd1b	22	7	deemed	deem	VBN
cord-266948-n7sltd1b	22	8	necessary	necessary	JJ
cord-266948-n7sltd1b	22	9	,	,	,
cord-266948-n7sltd1b	22	10	then	then	RB
cord-266948-n7sltd1b	22	11	thrombus	thrombus	NN
cord-266948-n7sltd1b	22	12	formation	formation	NN
cord-266948-n7sltd1b	22	13	must	must	MD
cord-266948-n7sltd1b	22	14	be	be	VB
cord-266948-n7sltd1b	22	15	carefully	carefully	RB
cord-266948-n7sltd1b	22	16	monitored	monitor	VBN
cord-266948-n7sltd1b	22	17	.	.	.
cord-266948-n7sltd1b	23	1	4	4	LS
cord-266948-n7sltd1b	23	2	.	.	.
cord-266948-n7sltd1b	24	1	Although	although	IN
cord-266948-n7sltd1b	24	2	not	not	RB
cord-266948-n7sltd1b	24	3	approved	approve	VBN
cord-266948-n7sltd1b	24	4	for	for	IN
cord-266948-n7sltd1b	24	5	treating	treat	VBG
cord-266948-n7sltd1b	24	6	COVID-19	covid-19	JJ
cord-266948-n7sltd1b	24	7	,	,	,
cord-266948-n7sltd1b	24	8	antiviral	antiviral	JJ
cord-266948-n7sltd1b	24	9	drugs	drug	NNS
cord-266948-n7sltd1b	24	10	(	(	-LRB-
cord-266948-n7sltd1b	24	11	eg	eg	IN
cord-266948-n7sltd1b	24	12	,	,	,
cord-266948-n7sltd1b	24	13	ritonavir	ritonavir	NNP
cord-266948-n7sltd1b	24	14	/	/	SYM
cord-266948-n7sltd1b	24	15	lopinavir	lopinavir	NNS
cord-266948-n7sltd1b	24	16	)	)	-RRB-
cord-266948-n7sltd1b	24	17	and	and	CC
cord-266948-n7sltd1b	24	18	the	the	DT
cord-266948-n7sltd1b	24	19	potential	potential	JJ
cord-266948-n7sltd1b	24	20	antiviral	antiviral	JJ
cord-266948-n7sltd1b	24	21	drug	drug	NN
cord-266948-n7sltd1b	24	22	hydroxychloroquine	hydroxychloroquine	NNP
cord-266948-n7sltd1b	24	23	are	be	VBP
cord-266948-n7sltd1b	24	24	in	in	IN
cord-266948-n7sltd1b	24	25	clinical	clinical	JJ
cord-266948-n7sltd1b	24	26	trials	trial	NNS
cord-266948-n7sltd1b	24	27	and	and	CC
cord-266948-n7sltd1b	24	28	being	be	VBG
cord-266948-n7sltd1b	24	29	used	use	VBN
cord-266948-n7sltd1b	24	30	empirically	empirically	RB
cord-266948-n7sltd1b	24	31	to	to	TO
cord-266948-n7sltd1b	24	32	treat	treat	VB
cord-266948-n7sltd1b	24	33	patients	patient	NNS
cord-266948-n7sltd1b	24	34	with	with	IN
cord-266948-n7sltd1b	24	35	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	24	36	.	.	.
cord-266948-n7sltd1b	25	1	The	the	DT
cord-266948-n7sltd1b	25	2	use	use	NN
cord-266948-n7sltd1b	25	3	of	of	IN
cord-266948-n7sltd1b	25	4	ritonavir	ritonavir	NNS
cord-266948-n7sltd1b	25	5	/	/	SYM
cord-266948-n7sltd1b	25	6	lopinavir	lopinavir	NNS
cord-266948-n7sltd1b	25	7	and	and	CC
cord-266948-n7sltd1b	25	8	hydroxychloroquine	hydroxychloroquine	NNP
cord-266948-n7sltd1b	25	9	are	be	VBP
cord-266948-n7sltd1b	25	10	associated	associate	VBN
cord-266948-n7sltd1b	25	11	with	with	IN
cord-266948-n7sltd1b	25	12	cardiovascular	cardiovascular	JJ
cord-266948-n7sltd1b	25	13	disease	disease	NN
cord-266948-n7sltd1b	25	14	.	.	.
cord-266948-n7sltd1b	26	1	The	the	DT
cord-266948-n7sltd1b	26	2	antiviral	antiviral	JJ
cord-266948-n7sltd1b	26	3	drug	drug	NN
cord-266948-n7sltd1b	26	4	remdesivir	remdesivir	NNP
cord-266948-n7sltd1b	26	5	has	have	VBZ
cord-266948-n7sltd1b	26	6	shown	show	VBN
cord-266948-n7sltd1b	26	7	some	some	DT
cord-266948-n7sltd1b	26	8	initial	initial	JJ
cord-266948-n7sltd1b	26	9	promise	promise	NN
cord-266948-n7sltd1b	26	10	in	in	IN
cord-266948-n7sltd1b	26	11	treating	treat	VBG
cord-266948-n7sltd1b	26	12	COVID-19	covid-19	NN
cord-266948-n7sltd1b	26	13	and	and	CC
cord-266948-n7sltd1b	26	14	has	have	VBZ
cord-266948-n7sltd1b	26	15	received	receive	VBN
cord-266948-n7sltd1b	26	16	Emergency	Emergency	NNP
cord-266948-n7sltd1b	26	17	Use	Use	NNP
cord-266948-n7sltd1b	26	18	Authorization	Authorization	NNP
cord-266948-n7sltd1b	26	19	from	from	IN
cord-266948-n7sltd1b	26	20	the	the	DT
cord-266948-n7sltd1b	26	21	US	US	NNP
cord-266948-n7sltd1b	26	22	Food	Food	NNP
cord-266948-n7sltd1b	26	23	and	and	CC
cord-266948-n7sltd1b	26	24	Drug	Drug	NNP
cord-266948-n7sltd1b	26	25	Agency	Agency	NNP
cord-266948-n7sltd1b	26	26	to	to	TO
cord-266948-n7sltd1b	26	27	treat	treat	VB
cord-266948-n7sltd1b	26	28	patients	patient	NNS
cord-266948-n7sltd1b	26	29	hospitalised	hospitalise	VBN
cord-266948-n7sltd1b	26	30	with	with	IN
cord-266948-n7sltd1b	26	31	severe	severe	JJ
cord-266948-n7sltd1b	26	32	COVID-19	covid-19	NN
cord-266948-n7sltd1b	26	33	.	.	.
cord-266948-n7sltd1b	27	1	There	there	EX
cord-266948-n7sltd1b	27	2	are	be	VBP
cord-266948-n7sltd1b	27	3	no	no	DT
cord-266948-n7sltd1b	27	4	reports	report	NNS
cord-266948-n7sltd1b	27	5	to	to	IN
cord-266948-n7sltd1b	27	6	date	date	NN
cord-266948-n7sltd1b	27	7	assessing	assess	VBG
cord-266948-n7sltd1b	27	8	the	the	DT
cord-266948-n7sltd1b	27	9	effect	effect	NN
cord-266948-n7sltd1b	27	10	of	of	IN
cord-266948-n7sltd1b	27	11	remdesivir	remdesivir	NNP
cord-266948-n7sltd1b	27	12	on	on	IN
cord-266948-n7sltd1b	27	13	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	27	14	or	or	CC
cord-266948-n7sltd1b	27	15	cardiovascular	cardiovascular	JJ
cord-266948-n7sltd1b	27	16	disease	disease	NN
cord-266948-n7sltd1b	27	17	,	,	,
cord-266948-n7sltd1b	27	18	including	include	VBG
cord-266948-n7sltd1b	27	19	AS	as	IN
cord-266948-n7sltd1b	27	20	.	.	.
cord-266948-n7sltd1b	28	1	However	however	RB
cord-266948-n7sltd1b	28	2	,	,	,
cord-266948-n7sltd1b	28	3	the	the	DT
cord-266948-n7sltd1b	28	4	effects	effect	NNS
cord-266948-n7sltd1b	28	5	of	of	IN
cord-266948-n7sltd1b	28	6	these	these	DT
cord-266948-n7sltd1b	28	7	drugs	drug	NNS
cord-266948-n7sltd1b	28	8	on	on	IN
cord-266948-n7sltd1b	28	9	valvular	valvular	JJ
cord-266948-n7sltd1b	28	10	disease	disease	NN
cord-266948-n7sltd1b	28	11	,	,	,
cord-266948-n7sltd1b	28	12	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	28	13	and	and	CC
cord-266948-n7sltd1b	28	14	other	other	JJ
cord-266948-n7sltd1b	28	15	cardiovascular	cardiovascular	JJ
cord-266948-n7sltd1b	28	16	disease	disease	NN
cord-266948-n7sltd1b	28	17	can	can	MD
cord-266948-n7sltd1b	28	18	not	not	RB
cord-266948-n7sltd1b	28	19	be	be	VB
cord-266948-n7sltd1b	28	20	ruled	rule	VBN
cord-266948-n7sltd1b	28	21	out	out	RP
cord-266948-n7sltd1b	28	22	.	.	.
cord-266948-n7sltd1b	29	1	5	5	LS
cord-266948-n7sltd1b	29	2	.	.	.
cord-266948-n7sltd1b	30	1	Clearly	clearly	RB
cord-266948-n7sltd1b	30	2	,	,	,
cord-266948-n7sltd1b	30	3	patients	patient	NNS
cord-266948-n7sltd1b	30	4	with	with	IN
cord-266948-n7sltd1b	30	5	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	30	6	are	be	VBP
cord-266948-n7sltd1b	30	7	highly	highly	RB
cord-266948-n7sltd1b	30	8	prothrombotic	prothrombotic	JJ
cord-266948-n7sltd1b	30	9	with	with	IN
cord-266948-n7sltd1b	30	10	unknown	unknown	JJ
cord-266948-n7sltd1b	30	11	aetiology	aetiology	NN
cord-266948-n7sltd1b	30	12	.	.	.
cord-266948-n7sltd1b	31	1	D	d	NN
cord-266948-n7sltd1b	31	2	-	-	HYPH
cord-266948-n7sltd1b	31	3	dimer	dimer	NN
cord-266948-n7sltd1b	31	4	is	be	VBZ
cord-266948-n7sltd1b	31	5	markedly	markedly	RB
cord-266948-n7sltd1b	31	6	elevated	elevate	VBN
cord-266948-n7sltd1b	31	7	in	in	IN
cord-266948-n7sltd1b	31	8	many	many	JJ
cord-266948-n7sltd1b	31	9	patients	patient	NNS
cord-266948-n7sltd1b	31	10	,	,	,
cord-266948-n7sltd1b	31	11	and	and	CC
cord-266948-n7sltd1b	31	12	meta	meta	NNP
cord-266948-n7sltd1b	31	13	-	-	HYPH
cord-266948-n7sltd1b	31	14	analysis	analysis	NNP
cord-266948-n7sltd1b	31	15	revealed	reveal	VBD
cord-266948-n7sltd1b	31	16	its	-PRON-	PRP$
cord-266948-n7sltd1b	31	17	association	association	NN
cord-266948-n7sltd1b	31	18	with	with	IN
cord-266948-n7sltd1b	31	19	disease	disease	NN
cord-266948-n7sltd1b	31	20	severity	severity	NN
cord-266948-n7sltd1b	31	21	and	and	CC
cord-266948-n7sltd1b	31	22	mortality	mortality	NN
cord-266948-n7sltd1b	31	23	.	.	.
cord-266948-n7sltd1b	32	1	7	7	CD
cord-266948-n7sltd1b	33	1	Therefore	therefore	RB
cord-266948-n7sltd1b	33	2	,	,	,
cord-266948-n7sltd1b	33	3	it	-PRON-	PRP
cord-266948-n7sltd1b	33	4	is	be	VBZ
cord-266948-n7sltd1b	33	5	critical	critical	JJ
cord-266948-n7sltd1b	33	6	to	to	TO
cord-266948-n7sltd1b	33	7	determine	determine	VB
cord-266948-n7sltd1b	33	8	which	which	WDT
cord-266948-n7sltd1b	33	9	anticoagulant	anticoagulant	NN
cord-266948-n7sltd1b	33	10	should	should	MD
cord-266948-n7sltd1b	33	11	be	be	VB
cord-266948-n7sltd1b	33	12	used	use	VBN
cord-266948-n7sltd1b	33	13	in	in	IN
cord-266948-n7sltd1b	33	14	addition	addition	NN
cord-266948-n7sltd1b	33	15	to	to	IN
cord-266948-n7sltd1b	33	16	the	the	DT
cord-266948-n7sltd1b	33	17	normal	normal	JJ
cord-266948-n7sltd1b	33	18	prophylaxis	prophylaxis	NN
cord-266948-n7sltd1b	33	19	regimens	regimen	NNS
cord-266948-n7sltd1b	33	20	,	,	,
cord-266948-n7sltd1b	33	21	since	since	IN
cord-266948-n7sltd1b	33	22	these	these	DT
cord-266948-n7sltd1b	33	23	are	be	VBP
cord-266948-n7sltd1b	33	24	not	not	RB
cord-266948-n7sltd1b	33	25	very	very	RB
cord-266948-n7sltd1b	33	26	effective	effective	JJ
cord-266948-n7sltd1b	33	27	in	in	IN
cord-266948-n7sltd1b	33	28	patients	patient	NNS
cord-266948-n7sltd1b	33	29	with	with	IN
cord-266948-n7sltd1b	33	30	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	33	31	.	.	.
cord-266948-n7sltd1b	34	1	Recent	recent	JJ
cord-266948-n7sltd1b	34	2	data	datum	NNS
cord-266948-n7sltd1b	34	3	from	from	IN
cord-266948-n7sltd1b	34	4	our	-PRON-	PRP$
cord-266948-n7sltd1b	34	5	group	group	NN
cord-266948-n7sltd1b	34	6	,	,	,
cord-266948-n7sltd1b	34	7	showed	show	VBD
cord-266948-n7sltd1b	34	8	a	a	DT
cord-266948-n7sltd1b	34	9	superior	superior	JJ
cord-266948-n7sltd1b	34	10	effect	effect	NN
cord-266948-n7sltd1b	34	11	of	of	IN
cord-266948-n7sltd1b	34	12	the	the	DT
cord-266948-n7sltd1b	34	13	direct	direct	JJ
cord-266948-n7sltd1b	34	14	thrombin	thrombin	JJ
cord-266948-n7sltd1b	34	15	inhibitor	inhibitor	NN
cord-266948-n7sltd1b	34	16	,	,	,
cord-266948-n7sltd1b	34	17	argatroban	argatroban	VBN
cord-266948-n7sltd1b	34	18	in	in	IN
cord-266948-n7sltd1b	34	19	reducing	reduce	VBG
cord-266948-n7sltd1b	34	20	circuit	circuit	NN
cord-266948-n7sltd1b	34	21	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	34	22	and	and	CC
cord-266948-n7sltd1b	34	23	D	d	NN
cord-266948-n7sltd1b	34	24	-	-	HYPH
cord-266948-n7sltd1b	34	25	dimer	dimer	NN
cord-266948-n7sltd1b	34	26	,	,	,
cord-266948-n7sltd1b	34	27	whereas	whereas	IN
cord-266948-n7sltd1b	34	28	therapeutic	therapeutic	JJ
cord-266948-n7sltd1b	34	29	dosage	dosage	NN
cord-266948-n7sltd1b	34	30	of	of	IN
cord-266948-n7sltd1b	34	31	heparin	heparin	NN
cord-266948-n7sltd1b	34	32	failed	fail	VBD
cord-266948-n7sltd1b	34	33	to	to	TO
cord-266948-n7sltd1b	34	34	prevent	prevent	VB
cord-266948-n7sltd1b	34	35	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	34	36	.	.	.
cord-266948-n7sltd1b	35	1	5	5	LS
cord-266948-n7sltd1b	36	1	Therefore	therefore	RB
cord-266948-n7sltd1b	36	2	,	,	,
cord-266948-n7sltd1b	36	3	direct	direct	JJ
cord-266948-n7sltd1b	36	4	thrombin	thrombin	NN
cord-266948-n7sltd1b	36	5	inhibitors	inhibitor	NNS
cord-266948-n7sltd1b	36	6	should	should	MD
cord-266948-n7sltd1b	36	7	be	be	VB
cord-266948-n7sltd1b	36	8	considered	consider	VBN
cord-266948-n7sltd1b	36	9	for	for	IN
cord-266948-n7sltd1b	36	10	AS	as	IN
cord-266948-n7sltd1b	36	11	patients	patient	NNS
cord-266948-n7sltd1b	36	12	who	who	WP
cord-266948-n7sltd1b	36	13	test	test	VBP
cord-266948-n7sltd1b	36	14	positive	positive	JJ
cord-266948-n7sltd1b	36	15	for	for	IN
cord-266948-n7sltd1b	36	16	SARS	SARS	NNP
cord-266948-n7sltd1b	36	17	-	-	HYPH
cord-266948-n7sltd1b	36	18	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	36	19	,	,	,
cord-266948-n7sltd1b	36	20	since	since	IN
cord-266948-n7sltd1b	36	21	both	both	DT
cord-266948-n7sltd1b	36	22	COVID-19	covid-19	VBP
cord-266948-n7sltd1b	36	23	and	and	CC
cord-266948-n7sltd1b	36	24	AS	as	IN
cord-266948-n7sltd1b	36	25	procedure	procedure	NN
cord-266948-n7sltd1b	36	26	can	can	MD
cord-266948-n7sltd1b	36	27	increase	increase	VB
cord-266948-n7sltd1b	36	28	the	the	DT
cord-266948-n7sltd1b	36	29	risk	risk	NN
cord-266948-n7sltd1b	36	30	of	of	IN
cord-266948-n7sltd1b	36	31	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	36	32	.	.	.
cord-266948-n7sltd1b	37	1	6	6	LS
cord-266948-n7sltd1b	37	2	.	.	.
cord-266948-n7sltd1b	38	1	If	if	IN
cord-266948-n7sltd1b	38	2	AS	as	IN
cord-266948-n7sltd1b	38	3	patients	patient	NNS
cord-266948-n7sltd1b	38	4	have	have	VBP
cord-266948-n7sltd1b	38	5	COVID-19	covid-19	CD
cord-266948-n7sltd1b	38	6	and	and	CC
cord-266948-n7sltd1b	38	7	shortness	shortness	NN
cord-266948-n7sltd1b	38	8	of	of	IN
cord-266948-n7sltd1b	38	9	breath	breath	NN
cord-266948-n7sltd1b	38	10	,	,	,
cord-266948-n7sltd1b	38	11	the	the	DT
cord-266948-n7sltd1b	38	12	risk	risk	NN
cord-266948-n7sltd1b	38	13	of	of	IN
cord-266948-n7sltd1b	38	14	morbidities	morbidity	NNS
cord-266948-n7sltd1b	38	15	is	be	VBZ
cord-266948-n7sltd1b	38	16	increased	increase	VBN
cord-266948-n7sltd1b	38	17	,	,	,
cord-266948-n7sltd1b	38	18	as	as	IN
cord-266948-n7sltd1b	38	19	shortness	shortness	NN
cord-266948-n7sltd1b	38	20	of	of	IN
cord-266948-n7sltd1b	38	21	breath	breath	NN
cord-266948-n7sltd1b	38	22	can	can	MD
cord-266948-n7sltd1b	38	23	be	be	VB
cord-266948-n7sltd1b	38	24	caused	cause	VBN
cord-266948-n7sltd1b	38	25	by	by	IN
cord-266948-n7sltd1b	38	26	either	either	DT
cord-266948-n7sltd1b	38	27	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	38	28	or	or	CC
cord-266948-n7sltd1b	38	29	AS	AS	NNP
cord-266948-n7sltd1b	38	30	.	.	.
cord-266948-n7sltd1b	39	1	Under	under	IN
cord-266948-n7sltd1b	39	2	such	such	JJ
cord-266948-n7sltd1b	39	3	circumstance	circumstance	NN
cord-266948-n7sltd1b	39	4	,	,	,
cord-266948-n7sltd1b	39	5	echocardiography	echocardiography	NN
cord-266948-n7sltd1b	39	6	is	be	VBZ
cord-266948-n7sltd1b	39	7	important	important	JJ
cord-266948-n7sltd1b	39	8	for	for	IN
cord-266948-n7sltd1b	39	9	accurate	accurate	JJ
cord-266948-n7sltd1b	39	10	diagnosis	diagnosis	NN
cord-266948-n7sltd1b	39	11	of	of	IN
cord-266948-n7sltd1b	39	12	the	the	DT
cord-266948-n7sltd1b	39	13	status	status	NN
cord-266948-n7sltd1b	39	14	of	of	IN
cord-266948-n7sltd1b	39	15	the	the	DT
cord-266948-n7sltd1b	39	16	patient	patient	NN
cord-266948-n7sltd1b	39	17	's	's	POS
cord-266948-n7sltd1b	39	18	AS	AS	NNP
cord-266948-n7sltd1b	39	19	.	.	.
cord-266948-n7sltd1b	40	1	If	if	IN
cord-266948-n7sltd1b	40	2	the	the	DT
cord-266948-n7sltd1b	40	3	shortness	shortness	NN
cord-266948-n7sltd1b	40	4	of	of	IN
cord-266948-n7sltd1b	40	5	breath	breath	NN
cord-266948-n7sltd1b	40	6	is	be	VBZ
cord-266948-n7sltd1b	40	7	not	not	RB
cord-266948-n7sltd1b	40	8	caused	cause	VBN
cord-266948-n7sltd1b	40	9	by	by	IN
cord-266948-n7sltd1b	40	10	AS	AS	NNP
cord-266948-n7sltd1b	40	11	,	,	,
cord-266948-n7sltd1b	40	12	markers	marker	NNS
cord-266948-n7sltd1b	40	13	for	for	IN
cord-266948-n7sltd1b	40	14	COVID-19	covid-19	CD
cord-266948-n7sltd1b	40	15	,	,	,
cord-266948-n7sltd1b	40	16	such	such	JJ
cord-266948-n7sltd1b	40	17	as	as	IN
cord-266948-n7sltd1b	40	18	interleukin-6	interleukin-6	NNP
cord-266948-n7sltd1b	40	19	,	,	,
cord-266948-n7sltd1b	40	20	D	d	NN
cord-266948-n7sltd1b	40	21	-	-	HYPH
cord-266948-n7sltd1b	40	22	dimer	dimer	NN
cord-266948-n7sltd1b	40	23	and	and	CC
cord-266948-n7sltd1b	40	24	complement	complement	VB
cord-266948-n7sltd1b	40	25	proteins	protein	NNS
cord-266948-n7sltd1b	40	26	and	and	CC
cord-266948-n7sltd1b	40	27	white	white	JJ
cord-266948-n7sltd1b	40	28	cell	cell	NN
cord-266948-n7sltd1b	40	29	counts	count	NNS
cord-266948-n7sltd1b	40	30	,	,	,
cord-266948-n7sltd1b	40	31	and	and	CC
cord-266948-n7sltd1b	40	32	acute	acute	JJ
cord-266948-n7sltd1b	40	33	white	white	JJ
cord-266948-n7sltd1b	40	34	cell	cell	NN
cord-266948-n7sltd1b	40	35	counts	count	NNS
cord-266948-n7sltd1b	40	36	should	should	MD
cord-266948-n7sltd1b	40	37	be	be	VB
cord-266948-n7sltd1b	40	38	examined	examine	VBN
cord-266948-n7sltd1b	40	39	,	,	,
cord-266948-n7sltd1b	40	40	as	as	IN
cord-266948-n7sltd1b	40	41	these	these	DT
cord-266948-n7sltd1b	40	42	levels	level	NNS
cord-266948-n7sltd1b	40	43	should	should	MD
cord-266948-n7sltd1b	40	44	not	not	RB
cord-266948-n7sltd1b	40	45	rise	rise	VB
cord-266948-n7sltd1b	40	46	in	in	IN
cord-266948-n7sltd1b	40	47	stable	stable	JJ
cord-266948-n7sltd1b	40	48	AS	as	IN
cord-266948-n7sltd1b	40	49	patients	patient	NNS
cord-266948-n7sltd1b	40	50	.	.	.
cord-266948-n7sltd1b	41	1	If	if	IN
cord-266948-n7sltd1b	41	2	,	,	,
cord-266948-n7sltd1b	41	3	however	however	RB
cord-266948-n7sltd1b	41	4	,	,	,
cord-266948-n7sltd1b	41	5	the	the	DT
cord-266948-n7sltd1b	41	6	respiratory	respiratory	JJ
cord-266948-n7sltd1b	41	7	symptom	symptom	NN
cord-266948-n7sltd1b	41	8	is	be	VBZ
cord-266948-n7sltd1b	41	9	the	the	DT
cord-266948-n7sltd1b	41	10	result	result	NN
cord-266948-n7sltd1b	41	11	of	of	IN
cord-266948-n7sltd1b	41	12	AS	AS	NNP
cord-266948-n7sltd1b	41	13	,	,	,
cord-266948-n7sltd1b	41	14	which	which	WDT
cord-266948-n7sltd1b	41	15	can	can	MD
cord-266948-n7sltd1b	41	16	be	be	VB
cord-266948-n7sltd1b	41	17	fatal	fatal	JJ
cord-266948-n7sltd1b	41	18	in	in	IN
cord-266948-n7sltd1b	41	19	itself	-PRON-	PRP
cord-266948-n7sltd1b	41	20	,	,	,
cord-266948-n7sltd1b	41	21	TAVR	TAVR	NNP
cord-266948-n7sltd1b	41	22	may	may	MD
cord-266948-n7sltd1b	41	23	be	be	VB
cord-266948-n7sltd1b	41	24	a	a	DT
cord-266948-n7sltd1b	41	25	better	well	JJR
cord-266948-n7sltd1b	41	26	option	option	NN
cord-266948-n7sltd1b	41	27	than	than	IN
cord-266948-n7sltd1b	41	28	AVR	AVR	NNP
cord-266948-n7sltd1b	41	29	considering	consider	VBG
cord-266948-n7sltd1b	41	30	the	the	DT
cord-266948-n7sltd1b	41	31	very	very	RB
cord-266948-n7sltd1b	41	32	high	high	JJ
cord-266948-n7sltd1b	41	33	-	-	HYPH
cord-266948-n7sltd1b	41	34	risk	risk	NN
cord-266948-n7sltd1b	41	35	status	status	NN
cord-266948-n7sltd1b	41	36	of	of	IN
cord-266948-n7sltd1b	41	37	patients	patient	NNS
cord-266948-n7sltd1b	41	38	with	with	IN
cord-266948-n7sltd1b	41	39	COVID-19	covid-19	JJ
cord-266948-n7sltd1b	41	40	comorbidities	comorbiditie	NNS
cord-266948-n7sltd1b	41	41	.	.	.
cord-266948-n7sltd1b	42	1	Concurrent	concurrent	JJ
cord-266948-n7sltd1b	42	2	monitoring	monitoring	NN
cord-266948-n7sltd1b	42	3	of	of	IN
cord-266948-n7sltd1b	42	4	the	the	DT
cord-266948-n7sltd1b	42	5	status	status	NN
cord-266948-n7sltd1b	42	6	of	of	IN
cord-266948-n7sltd1b	42	7	AS	as	IN
cord-266948-n7sltd1b	42	8	by	by	IN
cord-266948-n7sltd1b	42	9	echocardiography	echocardiography	NN
cord-266948-n7sltd1b	42	10	will	will	MD
cord-266948-n7sltd1b	42	11	avoid	avoid	VB
cord-266948-n7sltd1b	42	12	the	the	DT
cord-266948-n7sltd1b	42	13	complicating	complicate	VBG
cord-266948-n7sltd1b	42	14	comorbidity	comorbidity	NN
cord-266948-n7sltd1b	42	15	of	of	IN
cord-266948-n7sltd1b	42	16	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	42	17	,	,	,
cord-266948-n7sltd1b	42	18	for	for	IN
cord-266948-n7sltd1b	42	19	which	which	WDT
cord-266948-n7sltd1b	42	20	there	there	EX
cord-266948-n7sltd1b	42	21	are	be	VBP
cord-266948-n7sltd1b	42	22	currently	currently	RB
cord-266948-n7sltd1b	42	23	no	no	DT
cord-266948-n7sltd1b	42	24	clear	clear	JJ
cord-266948-n7sltd1b	42	25	treatment	treatment	NN
cord-266948-n7sltd1b	42	26	guidelines	guideline	NNS
cord-266948-n7sltd1b	42	27	for	for	IN
cord-266948-n7sltd1b	42	28	patients	patient	NNS
cord-266948-n7sltd1b	42	29	with	with	IN
cord-266948-n7sltd1b	42	30	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	42	31	.	.	NNP
cord-266948-n7sltd1b	42	32	7	7	CD
cord-266948-n7sltd1b	42	33	.	.	.
cord-266948-n7sltd1b	43	1	SARS	SARS	NNP
cord-266948-n7sltd1b	43	2	-	-	HYPH
cord-266948-n7sltd1b	43	3	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	43	4	enters	enter	VBZ
cord-266948-n7sltd1b	43	5	human	human	JJ
cord-266948-n7sltd1b	43	6	cells	cell	NNS
cord-266948-n7sltd1b	43	7	by	by	IN
cord-266948-n7sltd1b	43	8	binding	bind	VBG
cord-266948-n7sltd1b	43	9	of	of	IN
cord-266948-n7sltd1b	43	10	the	the	DT
cord-266948-n7sltd1b	43	11	viral	viral	JJ
cord-266948-n7sltd1b	43	12	spike	spike	NN
cord-266948-n7sltd1b	43	13	protein	protein	NN
cord-266948-n7sltd1b	43	14	to	to	IN
cord-266948-n7sltd1b	43	15	the	the	DT
cord-266948-n7sltd1b	43	16	membrane	membrane	NN
cord-266948-n7sltd1b	43	17	-	-	HYPH
cord-266948-n7sltd1b	43	18	bound	bind	VBN
cord-266948-n7sltd1b	43	19	form	form	NN
cord-266948-n7sltd1b	43	20	of	of	IN
cord-266948-n7sltd1b	43	21	the	the	DT
cord-266948-n7sltd1b	43	22	aminopeptidase	aminopeptidase	NN
cord-266948-n7sltd1b	43	23	ACE2	ACE2	NNP
cord-266948-n7sltd1b	43	24	on	on	IN
cord-266948-n7sltd1b	43	25	cells	cell	NNS
cord-266948-n7sltd1b	43	26	.	.	.
cord-266948-n7sltd1b	44	1	ACE2	ACE2	NNP
cord-266948-n7sltd1b	44	2	plays	play	VBZ
cord-266948-n7sltd1b	44	3	an	an	DT
cord-266948-n7sltd1b	44	4	important	important	JJ
cord-266948-n7sltd1b	44	5	regulatory	regulatory	JJ
cord-266948-n7sltd1b	44	6	role	role	NN
cord-266948-n7sltd1b	44	7	in	in	IN
cord-266948-n7sltd1b	44	8	the	the	DT
cord-266948-n7sltd1b	44	9	renin	renin	NN
cord-266948-n7sltd1b	44	10	-	-	HYPH
cord-266948-n7sltd1b	44	11	angiotensin	angiotensin	NN
cord-266948-n7sltd1b	44	12	system	system	NN
cord-266948-n7sltd1b	44	13	,	,	,
cord-266948-n7sltd1b	44	14	which	which	WDT
cord-266948-n7sltd1b	44	15	regulates	regulate	VBZ
cord-266948-n7sltd1b	44	16	normal	normal	JJ
cord-266948-n7sltd1b	44	17	and	and	CC
cord-266948-n7sltd1b	44	18	pathological	pathological	JJ
cord-266948-n7sltd1b	44	19	vascular	vascular	JJ
cord-266948-n7sltd1b	44	20	tone	tone	NN
cord-266948-n7sltd1b	44	21	and	and	CC
cord-266948-n7sltd1b	44	22	blood	blood	NN
cord-266948-n7sltd1b	44	23	pressure	pressure	NN
cord-266948-n7sltd1b	44	24	.	.	.
cord-266948-n7sltd1b	45	1	Various	various	JJ
cord-266948-n7sltd1b	45	2	types	type	NNS
cord-266948-n7sltd1b	45	3	of	of	IN
cord-266948-n7sltd1b	45	4	medications	medication	NNS
cord-266948-n7sltd1b	45	5	that	that	WDT
cord-266948-n7sltd1b	45	6	inhibit	inhibit	VBP
cord-266948-n7sltd1b	45	7	this	this	DT
cord-266948-n7sltd1b	45	8	system	system	NN
cord-266948-n7sltd1b	45	9	are	be	VBP
cord-266948-n7sltd1b	45	10	used	use	VBN
cord-266948-n7sltd1b	45	11	to	to	TO
cord-266948-n7sltd1b	45	12	treat	treat	VB
cord-266948-n7sltd1b	45	13	patients	patient	NNS
cord-266948-n7sltd1b	45	14	suffering	suffer	VBG
cord-266948-n7sltd1b	45	15	from	from	IN
cord-266948-n7sltd1b	45	16	cardiovascular	cardiovascular	JJ
cord-266948-n7sltd1b	45	17	disease	disease	NN
cord-266948-n7sltd1b	45	18	,	,	,
cord-266948-n7sltd1b	45	19	including	include	VBG
cord-266948-n7sltd1b	45	20	those	those	DT
cord-266948-n7sltd1b	45	21	with	with	IN
cord-266948-n7sltd1b	45	22	AS	AS	NNP
cord-266948-n7sltd1b	45	23	,	,	,
cord-266948-n7sltd1b	45	24	although	although	IN
cord-266948-n7sltd1b	45	25	none	none	NN
cord-266948-n7sltd1b	45	26	successful	successful	JJ
cord-266948-n7sltd1b	45	27	in	in	IN
cord-266948-n7sltd1b	45	28	clinical	clinical	JJ
cord-266948-n7sltd1b	45	29	trial	trial	NN
cord-266948-n7sltd1b	45	30	for	for	IN
cord-266948-n7sltd1b	45	31	AS	AS	NNP
cord-266948-n7sltd1b	45	32	.	.	.
cord-266948-n7sltd1b	46	1	Studies	study	NNS
cord-266948-n7sltd1b	46	2	in	in	IN
cord-266948-n7sltd1b	46	3	animals	animal	NNS
cord-266948-n7sltd1b	46	4	have	have	VBP
cord-266948-n7sltd1b	46	5	suggested	suggest	VBN
cord-266948-n7sltd1b	46	6	that	that	IN
cord-266948-n7sltd1b	46	7	inhibitors	inhibitor	NNS
cord-266948-n7sltd1b	46	8	of	of	IN
cord-266948-n7sltd1b	46	9	this	this	DT
cord-266948-n7sltd1b	46	10	system	system	NN
cord-266948-n7sltd1b	46	11	can	can	MD
cord-266948-n7sltd1b	46	12	upregulate	upregulate	VB
cord-266948-n7sltd1b	46	13	ACE2	ACE2	NNP
cord-266948-n7sltd1b	46	14	expression	expression	NN
cord-266948-n7sltd1b	46	15	,	,	,
cord-266948-n7sltd1b	46	16	which	which	WDT
cord-266948-n7sltd1b	46	17	led	lead	VBD
cord-266948-n7sltd1b	46	18	some	some	DT
cord-266948-n7sltd1b	46	19	investigators	investigator	NNS
cord-266948-n7sltd1b	46	20	to	to	TO
cord-266948-n7sltd1b	46	21	postulate	postulate	VB
cord-266948-n7sltd1b	46	22	that	that	IN
cord-266948-n7sltd1b	46	23	patients	patient	NNS
cord-266948-n7sltd1b	46	24	receiving	receive	VBG
cord-266948-n7sltd1b	46	25	those	those	DT
cord-266948-n7sltd1b	46	26	inhibitors	inhibitor	NNS
cord-266948-n7sltd1b	46	27	may	may	MD
cord-266948-n7sltd1b	46	28	be	be	VB
cord-266948-n7sltd1b	46	29	at	at	IN
cord-266948-n7sltd1b	46	30	high	high	JJ
cord-266948-n7sltd1b	46	31	risk	risk	NN
cord-266948-n7sltd1b	46	32	of	of	IN
cord-266948-n7sltd1b	46	33	contracting	contract	VBG
cord-266948-n7sltd1b	46	34	a	a	DT
cord-266948-n7sltd1b	46	35	SARS	SARS	NNP
cord-266948-n7sltd1b	46	36	-	-	HYPH
cord-266948-n7sltd1b	46	37	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	46	38	infection	infection	NN
cord-266948-n7sltd1b	46	39	,	,	,
cord-266948-n7sltd1b	46	40	which	which	WDT
cord-266948-n7sltd1b	46	41	needs	need	VBZ
cord-266948-n7sltd1b	46	42	to	to	TO
cord-266948-n7sltd1b	46	43	be	be	VB
cord-266948-n7sltd1b	46	44	validated	validate	VBN
cord-266948-n7sltd1b	46	45	experimentally	experimentally	RB
cord-266948-n7sltd1b	46	46	.	.	.
cord-266948-n7sltd1b	47	1	8	8	CD
cord-266948-n7sltd1b	48	1	Therefore	therefore	RB
cord-266948-n7sltd1b	48	2	,	,	,
cord-266948-n7sltd1b	48	3	it	-PRON-	PRP
cord-266948-n7sltd1b	48	4	is	be	VBZ
cord-266948-n7sltd1b	48	5	critical	critical	JJ
cord-266948-n7sltd1b	48	6	to	to	TO
cord-266948-n7sltd1b	48	7	carefully	carefully	RB
cord-266948-n7sltd1b	48	8	assess	assess	VB
cord-266948-n7sltd1b	48	9	and	and	CC
cord-266948-n7sltd1b	48	10	differentiate	differentiate	VB
cord-266948-n7sltd1b	48	11	symptoms	symptom	NNS
cord-266948-n7sltd1b	48	12	in	in	IN
cord-266948-n7sltd1b	48	13	acute	acute	JJ
cord-266948-n7sltd1b	48	14	AS	as	IN
cord-266948-n7sltd1b	48	15	versus	versus	IN
cord-266948-n7sltd1b	48	16	COVID-19	covid-19	CD
cord-266948-n7sltd1b	48	17	cases	case	NNS
cord-266948-n7sltd1b	48	18	wherein	wherein	VBZ
cord-266948-n7sltd1b	48	19	comorbidities	comorbiditie	NNS
cord-266948-n7sltd1b	48	20	and	and	CC
cord-266948-n7sltd1b	48	21	risk	risk	NN
cord-266948-n7sltd1b	48	22	always	always	RB
cord-266948-n7sltd1b	48	23	rise	rise	VBP
cord-266948-n7sltd1b	48	24	.	.	.
cord-266948-n7sltd1b	49	1	If	if	IN
cord-266948-n7sltd1b	49	2	the	the	DT
cord-266948-n7sltd1b	49	3	AS	AS	NNP
cord-266948-n7sltd1b	49	4	patient	patient	NN
cord-266948-n7sltd1b	49	5	can	can	MD
cord-266948-n7sltd1b	49	6	not	not	RB
cord-266948-n7sltd1b	49	7	delay	delay	VB
cord-266948-n7sltd1b	49	8	life	life	NN
cord-266948-n7sltd1b	49	9	-	-	HYPH
cord-266948-n7sltd1b	49	10	saving	save	VBG
cord-266948-n7sltd1b	49	11	procedures	procedure	NNS
cord-266948-n7sltd1b	49	12	and	and	CC
cord-266948-n7sltd1b	49	13	are	be	VBP
cord-266948-n7sltd1b	49	14	taking	take	VBG
cord-266948-n7sltd1b	49	15	the	the	DT
cord-266948-n7sltd1b	49	16	ACE	ACE	NNP
cord-266948-n7sltd1b	49	17	inhibitors	inhibitor	NNS
cord-266948-n7sltd1b	49	18	,	,	,
cord-266948-n7sltd1b	49	19	which	which	WDT
cord-266948-n7sltd1b	49	20	can	can	MD
cord-266948-n7sltd1b	49	21	be	be	VB
cord-266948-n7sltd1b	49	22	discontinued	discontinue	VBN
cord-266948-n7sltd1b	49	23	but	but	CC
cord-266948-n7sltd1b	49	24	,	,	,
cord-266948-n7sltd1b	49	25	as	as	IN
cord-266948-n7sltd1b	49	26	discussed	discuss	VBN
cord-266948-n7sltd1b	49	27	above	above	RB
cord-266948-n7sltd1b	49	28	,	,	,
cord-266948-n7sltd1b	49	29	other	other	JJ
cord-266948-n7sltd1b	49	30	challenges	challenge	NNS
cord-266948-n7sltd1b	49	31	,	,	,
cord-266948-n7sltd1b	49	32	such	such	JJ
cord-266948-n7sltd1b	49	33	as	as	IN
cord-266948-n7sltd1b	49	34	management	management	NN
cord-266948-n7sltd1b	49	35	of	of	IN
cord-266948-n7sltd1b	49	36	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	49	37	,	,	,
cord-266948-n7sltd1b	49	38	also	also	RB
cord-266948-n7sltd1b	49	39	need	need	VBP
cord-266948-n7sltd1b	49	40	careful	careful	JJ
cord-266948-n7sltd1b	49	41	consideration	consideration	NN
cord-266948-n7sltd1b	49	42	.	.	.
cord-266948-n7sltd1b	50	1	The	the	DT
cord-266948-n7sltd1b	50	2	disease	disease	NN
cord-266948-n7sltd1b	50	3	-	-	HYPH
cord-266948-n7sltd1b	50	4	causing	cause	VBG
cord-266948-n7sltd1b	50	5	mechanisms	mechanism	NNS
cord-266948-n7sltd1b	50	6	of	of	IN
cord-266948-n7sltd1b	50	7	both	both	DT
cord-266948-n7sltd1b	50	8	AS	AS	NNP
cord-266948-n7sltd1b	50	9	and	and	CC
cord-266948-n7sltd1b	50	10	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	50	11	are	be	VBP
cord-266948-n7sltd1b	50	12	not	not	RB
cord-266948-n7sltd1b	50	13	well	well	RB
cord-266948-n7sltd1b	50	14	known	known	JJ
cord-266948-n7sltd1b	50	15	.	.	.
cord-266948-n7sltd1b	51	1	Both	both	DT
cord-266948-n7sltd1b	51	2	are	be	VBP
cord-266948-n7sltd1b	51	3	associated	associate	VBN
cord-266948-n7sltd1b	51	4	with	with	IN
cord-266948-n7sltd1b	51	5	high	high	JJ
cord-266948-n7sltd1b	51	6	-	-	HYPH
cord-266948-n7sltd1b	51	7	risk	risk	NN
cord-266948-n7sltd1b	51	8	underlying	underlying	JJ
cord-266948-n7sltd1b	51	9	conditions	condition	NNS
cord-266948-n7sltd1b	51	10	,	,	,
cord-266948-n7sltd1b	51	11	including	include	VBG
cord-266948-n7sltd1b	51	12	age	age	NN
cord-266948-n7sltd1b	51	13	,	,	,
cord-266948-n7sltd1b	51	14	obesity	obesity	NN
cord-266948-n7sltd1b	51	15	,	,	,
cord-266948-n7sltd1b	51	16	diabetes	diabetes	NN
cord-266948-n7sltd1b	51	17	,	,	,
cord-266948-n7sltd1b	51	18	hypertension	hypertension	NN
cord-266948-n7sltd1b	51	19	and	and	CC
cord-266948-n7sltd1b	51	20	male	male	JJ
cord-266948-n7sltd1b	51	21	gender	gender	NN
cord-266948-n7sltd1b	51	22	,	,	,
cord-266948-n7sltd1b	51	23	which	which	WDT
cord-266948-n7sltd1b	51	24	increases	increase	VBZ
cord-266948-n7sltd1b	51	25	the	the	DT
cord-266948-n7sltd1b	51	26	complexity	complexity	NN
cord-266948-n7sltd1b	51	27	of	of	IN
cord-266948-n7sltd1b	51	28	comorbidities	comorbiditie	NNS
cord-266948-n7sltd1b	51	29	and	and	CC
cord-266948-n7sltd1b	51	30	decision	decision	NN
cord-266948-n7sltd1b	51	31	making	making	NN
cord-266948-n7sltd1b	51	32	,	,	,
cord-266948-n7sltd1b	51	33	especially	especially	RB
cord-266948-n7sltd1b	51	34	in	in	IN
cord-266948-n7sltd1b	51	35	the	the	DT
cord-266948-n7sltd1b	51	36	ICU	ICU	NNP
cord-266948-n7sltd1b	51	37	setting	set	VBG
cord-266948-n7sltd1b	51	38	when	when	WRB
cord-266948-n7sltd1b	51	39	patients	patient	NNS
cord-266948-n7sltd1b	51	40	are	be	VBP
cord-266948-n7sltd1b	51	41	on	on	IN
cord-266948-n7sltd1b	51	42	ventilators	ventilator	NNS
cord-266948-n7sltd1b	51	43	and	and	CC
cord-266948-n7sltd1b	51	44	oral	oral	JJ
cord-266948-n7sltd1b	51	45	treatments	treatment	NNS
cord-266948-n7sltd1b	51	46	are	be	VBP
cord-266948-n7sltd1b	51	47	not	not	RB
cord-266948-n7sltd1b	51	48	an	an	DT
cord-266948-n7sltd1b	51	49	option	option	NN
cord-266948-n7sltd1b	51	50	.	.	.
cord-266948-n7sltd1b	52	1	Thus	thus	RB
cord-266948-n7sltd1b	52	2	,	,	,
cord-266948-n7sltd1b	52	3	understanding	understand	VBG
cord-266948-n7sltd1b	52	4	the	the	DT
cord-266948-n7sltd1b	52	5	mechanisms	mechanism	NNS
cord-266948-n7sltd1b	52	6	of	of	IN
cord-266948-n7sltd1b	52	7	these	these	DT
cord-266948-n7sltd1b	52	8	two	two	CD
cord-266948-n7sltd1b	52	9	diseases	disease	NNS
cord-266948-n7sltd1b	52	10	is	be	VBZ
cord-266948-n7sltd1b	52	11	required	require	VBN
cord-266948-n7sltd1b	52	12	to	to	TO
cord-266948-n7sltd1b	52	13	improve	improve	VB
cord-266948-n7sltd1b	52	14	treatments	treatment	NNS
cord-266948-n7sltd1b	52	15	of	of	IN
cord-266948-n7sltd1b	52	16	these	these	DT
cord-266948-n7sltd1b	52	17	diseases	disease	NNS
cord-266948-n7sltd1b	52	18	separately	separately	RB
cord-266948-n7sltd1b	52	19	as	as	RB
cord-266948-n7sltd1b	52	20	well	well	RB
cord-266948-n7sltd1b	52	21	as	as	IN
cord-266948-n7sltd1b	52	22	when	when	WRB
cord-266948-n7sltd1b	52	23	they	-PRON-	PRP
cord-266948-n7sltd1b	52	24	occur	occur	VBP
cord-266948-n7sltd1b	52	25	together	together	RB
cord-266948-n7sltd1b	52	26	.	.	.
cord-266948-n7sltd1b	53	1	Because	because	IN
cord-266948-n7sltd1b	53	2	it	-PRON-	PRP
cord-266948-n7sltd1b	53	3	is	be	VBZ
cord-266948-n7sltd1b	53	4	almost	almost	RB
cord-266948-n7sltd1b	53	5	impossible	impossible	JJ
cord-266948-n7sltd1b	53	6	to	to	TO
cord-266948-n7sltd1b	53	7	test	test	VB
cord-266948-n7sltd1b	53	8	the	the	DT
cord-266948-n7sltd1b	53	9	mechanism	mechanism	NN
cord-266948-n7sltd1b	53	10	of	of	IN
cord-266948-n7sltd1b	53	11	AS	AS	NNP
cord-266948-n7sltd1b	53	12	or	or	CC
cord-266948-n7sltd1b	53	13	COVID-19	covid-19	VB
cord-266948-n7sltd1b	53	14	in	in	IN
cord-266948-n7sltd1b	53	15	humans	human	NNS
cord-266948-n7sltd1b	53	16	,	,	,
cord-266948-n7sltd1b	53	17	other	other	JJ
cord-266948-n7sltd1b	53	18	than	than	IN
cord-266948-n7sltd1b	53	19	correlative	correlative	JJ
cord-266948-n7sltd1b	53	20	studies	study	NNS
cord-266948-n7sltd1b	53	21	,	,	,
cord-266948-n7sltd1b	53	22	animal	animal	NN
cord-266948-n7sltd1b	53	23	studies	study	NNS
cord-266948-n7sltd1b	53	24	are	be	VBP
cord-266948-n7sltd1b	53	25	needed	need	VBN
cord-266948-n7sltd1b	53	26	.	.	.
cord-266948-n7sltd1b	54	1	We	-PRON-	PRP
cord-266948-n7sltd1b	54	2	have	have	VBP
cord-266948-n7sltd1b	54	3	established	establish	VBN
cord-266948-n7sltd1b	54	4	a	a	DT
cord-266948-n7sltd1b	54	5	new	new	JJ
cord-266948-n7sltd1b	54	6	robust	robust	JJ
cord-266948-n7sltd1b	54	7	mouse	mouse	NN
cord-266948-n7sltd1b	54	8	model	model	NN
cord-266948-n7sltd1b	54	9	of	of	IN
cord-266948-n7sltd1b	54	10	AS	as	IN
cord-266948-n7sltd1b	54	11	that	that	WDT
cord-266948-n7sltd1b	54	12	simulates	simulate	VBZ
cord-266948-n7sltd1b	54	13	AS	as	IN
cord-266948-n7sltd1b	54	14	in	in	IN
cord-266948-n7sltd1b	54	15	human	human	NN
cord-266948-n7sltd1b	54	16	and	and	CC
cord-266948-n7sltd1b	54	17	identified	identify	VBD
cord-266948-n7sltd1b	54	18	platelet	platelet	NN
cord-266948-n7sltd1b	54	19	transforming	transform	VBG
cord-266948-n7sltd1b	54	20	growth	growth	NN
cord-266948-n7sltd1b	54	21	factor	factor	NN
cord-266948-n7sltd1b	54	22	beta-1	beta-1	JJ
cord-266948-n7sltd1b	54	23	as	as	IN
cord-266948-n7sltd1b	54	24	a	a	DT
cord-266948-n7sltd1b	54	25	major	major	JJ
cord-266948-n7sltd1b	54	26	driver	driver	NN
cord-266948-n7sltd1b	54	27	of	of	IN
cord-266948-n7sltd1b	54	28	AS	as	JJ
cord-266948-n7sltd1b	54	29	progression	progression	NN
cord-266948-n7sltd1b	54	30	.	.	.
cord-266948-n7sltd1b	55	1	9	9	CD
cord-266948-n7sltd1b	56	1	The	the	DT
cord-266948-n7sltd1b	56	2	new	new	JJ
cord-266948-n7sltd1b	56	3	SARS	SARS	NNP
cord-266948-n7sltd1b	56	4	-	-	HYPH
cord-266948-n7sltd1b	56	5	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	56	6	animal	animal	NN
cord-266948-n7sltd1b	56	7	models	model	NNS
cord-266948-n7sltd1b	56	8	10	10	CD
cord-266948-n7sltd1b	56	9	can	can	MD
cord-266948-n7sltd1b	56	10	be	be	VB
cord-266948-n7sltd1b	56	11	adapted	adapt	VBN
cord-266948-n7sltd1b	56	12	to	to	IN
cord-266948-n7sltd1b	56	13	comorbid	comorbid	VB
cord-266948-n7sltd1b	56	14	disease	disease	NN
cord-266948-n7sltd1b	56	15	models	model	NNS
cord-266948-n7sltd1b	56	16	,	,	,
cord-266948-n7sltd1b	56	17	such	such	JJ
cord-266948-n7sltd1b	56	18	as	as	IN
cord-266948-n7sltd1b	56	19	AS	AS	NNP
cord-266948-n7sltd1b	56	20	,	,	,
cord-266948-n7sltd1b	56	21	to	to	TO
cord-266948-n7sltd1b	56	22	facilitate	facilitate	VB
cord-266948-n7sltd1b	56	23	the	the	DT
cord-266948-n7sltd1b	56	24	identification	identification	NN
cord-266948-n7sltd1b	56	25	of	of	IN
cord-266948-n7sltd1b	56	26	underlying	underlie	VBG
cord-266948-n7sltd1b	56	27	mechanisms	mechanism	NNS
cord-266948-n7sltd1b	56	28	.	.	.
cord-266948-n7sltd1b	57	1	These	these	DT
cord-266948-n7sltd1b	57	2	models	model	NNS
cord-266948-n7sltd1b	57	3	will	will	MD
cord-266948-n7sltd1b	57	4	potentially	potentially	RB
cord-266948-n7sltd1b	57	5	inform	inform	VB
cord-266948-n7sltd1b	57	6	the	the	DT
cord-266948-n7sltd1b	57	7	development	development	NN
cord-266948-n7sltd1b	57	8	of	of	IN
cord-266948-n7sltd1b	57	9	therapies	therapy	NNS
cord-266948-n7sltd1b	57	10	for	for	IN
cord-266948-n7sltd1b	57	11	AS	AS	NNP
cord-266948-n7sltd1b	57	12	and	and	CC
cord-266948-n7sltd1b	57	13	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	57	14	.	.	.
cord-266948-n7sltd1b	58	1	Finally	finally	RB
cord-266948-n7sltd1b	58	2	,	,	,
cord-266948-n7sltd1b	58	3	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	58	4	may	may	MD
cord-266948-n7sltd1b	58	5	pose	pose	VB
cord-266948-n7sltd1b	58	6	an	an	DT
cord-266948-n7sltd1b	58	7	additional	additional	JJ
cord-266948-n7sltd1b	58	8	risk	risk	NN
cord-266948-n7sltd1b	58	9	for	for	IN
cord-266948-n7sltd1b	58	10	other	other	JJ
cord-266948-n7sltd1b	58	11	life	life	NN
cord-266948-n7sltd1b	58	12	-	-	HYPH
cord-266948-n7sltd1b	58	13	saving	save	VBG
cord-266948-n7sltd1b	58	14	procedures	procedure	NNS
cord-266948-n7sltd1b	58	15	where	where	WRB
cord-266948-n7sltd1b	58	16	thromboembolic	thromboembolic	JJ
cord-266948-n7sltd1b	58	17	events	event	NNS
cord-266948-n7sltd1b	58	18	are	be	VBP
cord-266948-n7sltd1b	58	19	common	common	JJ
cord-266948-n7sltd1b	58	20	,	,	,
cord-266948-n7sltd1b	58	21	such	such	JJ
cord-266948-n7sltd1b	58	22	as	as	IN
cord-266948-n7sltd1b	58	23	cardiac	cardiac	JJ
cord-266948-n7sltd1b	58	24	catheterization	catheterization	NN
cord-266948-n7sltd1b	58	25	,	,	,
cord-266948-n7sltd1b	58	26	implantation	implantation	NN
cord-266948-n7sltd1b	58	27	of	of	IN
cord-266948-n7sltd1b	58	28	permanent	permanent	JJ
cord-266948-n7sltd1b	58	29	pacemaker	pacemaker	NN
cord-266948-n7sltd1b	58	30	and	and	CC
cord-266948-n7sltd1b	58	31	left	leave	VBN
cord-266948-n7sltd1b	58	32	ventricular	ventricular	JJ
cord-266948-n7sltd1b	58	33	assist	assist	VB
cord-266948-n7sltd1b	58	34	device	device	NN
cord-266948-n7sltd1b	58	35	in	in	IN
cord-266948-n7sltd1b	58	36	heart	heart	NN
cord-266948-n7sltd1b	58	37	failure	failure	NN
cord-266948-n7sltd1b	58	38	patients	patient	NNS
cord-266948-n7sltd1b	58	39	or	or	CC
cord-266948-n7sltd1b	58	40	thrombus	thrombus	NN
cord-266948-n7sltd1b	58	41	removal	removal	NN
cord-266948-n7sltd1b	58	42	in	in	IN
cord-266948-n7sltd1b	58	43	stroke	stroke	NN
cord-266948-n7sltd1b	58	44	patients	patient	NNS
cord-266948-n7sltd1b	58	45	.	.	.
cord-266948-n7sltd1b	59	1	Thus	thus	RB
cord-266948-n7sltd1b	59	2	,	,	,
cord-266948-n7sltd1b	59	3	caution	caution	NN
cord-266948-n7sltd1b	59	4	should	should	MD
cord-266948-n7sltd1b	59	5	be	be	VB
cord-266948-n7sltd1b	59	6	taken	take	VBN
cord-266948-n7sltd1b	59	7	if	if	IN
cord-266948-n7sltd1b	59	8	these	these	DT
cord-266948-n7sltd1b	59	9	procedures	procedure	NNS
cord-266948-n7sltd1b	59	10	are	be	VBP
cord-266948-n7sltd1b	59	11	deemed	deem	VBN
cord-266948-n7sltd1b	59	12	necessary	necessary	JJ
cord-266948-n7sltd1b	59	13	;	;	:
cord-266948-n7sltd1b	59	14	in	in	IN
cord-266948-n7sltd1b	59	15	particular	particular	JJ
cord-266948-n7sltd1b	59	16	,	,	,
cord-266948-n7sltd1b	59	17	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	59	18	and	and	CC
cord-266948-n7sltd1b	59	19	the	the	DT
cord-266948-n7sltd1b	59	20	effects	effect	NNS
cord-266948-n7sltd1b	59	21	of	of	IN
cord-266948-n7sltd1b	59	22	anticoagulants	anticoagulant	NNS
cord-266948-n7sltd1b	59	23	on	on	IN
cord-266948-n7sltd1b	59	24	bleeding	bleeding	NN
cord-266948-n7sltd1b	59	25	must	must	MD
cord-266948-n7sltd1b	59	26	be	be	VB
cord-266948-n7sltd1b	59	27	carefully	carefully	RB
cord-266948-n7sltd1b	59	28	monitored	monitor	VBN
cord-266948-n7sltd1b	59	29	.	.	.
cord-266948-n7sltd1b	60	1	Transcatheter	Transcatheter	NNP
cord-266948-n7sltd1b	60	2	versus	versus	IN
cord-266948-n7sltd1b	60	3	surgical	surgical	JJ
cord-266948-n7sltd1b	60	4	aortic	aortic	JJ
cord-266948-n7sltd1b	60	5	-	-	HYPH
cord-266948-n7sltd1b	60	6	valve	valve	NN
cord-266948-n7sltd1b	60	7	replacement	replacement	NN
cord-266948-n7sltd1b	60	8	in	in	IN
cord-266948-n7sltd1b	60	9	high	high	JJ
cord-266948-n7sltd1b	60	10	-	-	HYPH
cord-266948-n7sltd1b	60	11	risk	risk	NN
cord-266948-n7sltd1b	60	12	patients	patient	NNS
cord-266948-n7sltd1b	60	13	Complement	complement	VB
cord-266948-n7sltd1b	60	14	associated	associate	VBD
cord-266948-n7sltd1b	60	15	microvascular	microvascular	JJ
cord-266948-n7sltd1b	60	16	injury	injury	NN
cord-266948-n7sltd1b	60	17	and	and	CC
cord-266948-n7sltd1b	60	18	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	60	19	in	in	IN
cord-266948-n7sltd1b	60	20	the	the	DT
cord-266948-n7sltd1b	60	21	pathogenesis	pathogenesis	NN
cord-266948-n7sltd1b	60	22	of	of	IN
cord-266948-n7sltd1b	60	23	severe	severe	JJ
cord-266948-n7sltd1b	60	24	COVID-19	covid-19	JJ
cord-266948-n7sltd1b	60	25	infection	infection	NN
cord-266948-n7sltd1b	60	26	:	:	:
cord-266948-n7sltd1b	61	1	a	a	DT
cord-266948-n7sltd1b	61	2	report	report	NN
cord-266948-n7sltd1b	61	3	of	of	IN
cord-266948-n7sltd1b	61	4	five	five	CD
cord-266948-n7sltd1b	61	5	cases	case	NNS
cord-266948-n7sltd1b	61	6	COVID-19	covid-19	VBP
cord-266948-n7sltd1b	61	7	and	and	CC
cord-266948-n7sltd1b	61	8	its	-PRON-	PRP$
cord-266948-n7sltd1b	61	9	implications	implication	NNS
cord-266948-n7sltd1b	61	10	for	for	IN
cord-266948-n7sltd1b	61	11	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	61	12	and	and	CC
cord-266948-n7sltd1b	61	13	anticoagulation	anticoagulation	NN
cord-266948-n7sltd1b	61	14	How	how	WRB
cord-266948-n7sltd1b	61	15	to	to	TO
cord-266948-n7sltd1b	61	16	handle	handle	VB
cord-266948-n7sltd1b	61	17	elective	elective	JJ
cord-266948-n7sltd1b	61	18	surgeries	surgery	NNS
cord-266948-n7sltd1b	61	19	and	and	CC
cord-266948-n7sltd1b	61	20	procedures	procedure	NNS
cord-266948-n7sltd1b	61	21	during	during	IN
cord-266948-n7sltd1b	61	22	the	the	DT
cord-266948-n7sltd1b	61	23	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	61	24	pandemic	pandemic	NN
cord-266948-n7sltd1b	61	25	.	.	.
cord-266948-n7sltd1b	62	1	The	the	DT
cord-266948-n7sltd1b	62	2	National	National	NNP
cord-266948-n7sltd1b	62	3	Law	Law	NNP
cord-266948-n7sltd1b	62	4	Review	Review	NNP
cord-266948-n7sltd1b	62	5	Circuit	Circuit	NNP
cord-266948-n7sltd1b	62	6	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	62	7	reversed	reverse	VBD
cord-266948-n7sltd1b	62	8	and	and	CC
cord-266948-n7sltd1b	62	9	markers	marker	NNS
cord-266948-n7sltd1b	62	10	of	of	IN
cord-266948-n7sltd1b	62	11	a	a	DT
cord-266948-n7sltd1b	62	12	hypercoagulable	hypercoagulable	JJ
cord-266948-n7sltd1b	62	13	state	state	NN
cord-266948-n7sltd1b	62	14	decreased	decrease	VBN
cord-266948-n7sltd1b	62	15	by	by	IN
cord-266948-n7sltd1b	62	16	direct	direct	JJ
cord-266948-n7sltd1b	62	17	thrombin	thrombin	NN
cord-266948-n7sltd1b	62	18	inhibition	inhibition	NN
cord-266948-n7sltd1b	62	19	in	in	IN
cord-266948-n7sltd1b	62	20	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	62	21	Acute	acute	JJ
cord-266948-n7sltd1b	62	22	thrombosis	thrombosis	NN
cord-266948-n7sltd1b	62	23	of	of	IN
cord-266948-n7sltd1b	62	24	an	an	DT
cord-266948-n7sltd1b	62	25	aortic	aortic	JJ
cord-266948-n7sltd1b	62	26	prosthetic	prosthetic	JJ
cord-266948-n7sltd1b	62	27	graft	graft	NN
cord-266948-n7sltd1b	62	28	in	in	IN
cord-266948-n7sltd1b	62	29	a	a	DT
cord-266948-n7sltd1b	62	30	patient	patient	NN
cord-266948-n7sltd1b	62	31	with	with	IN
cord-266948-n7sltd1b	62	32	severe	severe	JJ
cord-266948-n7sltd1b	62	33	COVID-19-Related	covid-19-related	JJ
cord-266948-n7sltd1b	62	34	pneumonia	pneumonia	NN
cord-266948-n7sltd1b	63	1	Elevated	elevated	JJ
cord-266948-n7sltd1b	63	2	D	d	NN
cord-266948-n7sltd1b	63	3	-	-	HYPH
cord-266948-n7sltd1b	63	4	dimer	dimer	NN
cord-266948-n7sltd1b	63	5	levels	level	NNS
cord-266948-n7sltd1b	63	6	are	be	VBP
cord-266948-n7sltd1b	63	7	associated	associate	VBN
cord-266948-n7sltd1b	63	8	with	with	IN
cord-266948-n7sltd1b	63	9	increased	increase	VBN
cord-266948-n7sltd1b	63	10	risk	risk	NN
cord-266948-n7sltd1b	63	11	of	of	IN
cord-266948-n7sltd1b	63	12	mortality	mortality	NN
cord-266948-n7sltd1b	63	13	in	in	IN
cord-266948-n7sltd1b	63	14	COVID-19	COVID-19	NNP
cord-266948-n7sltd1b	63	15	:	:	:
cord-266948-n7sltd1b	63	16	a	a	DT
cord-266948-n7sltd1b	63	17	systematic	systematic	JJ
cord-266948-n7sltd1b	63	18	review	review	NN
cord-266948-n7sltd1b	63	19	and	and	CC
cord-266948-n7sltd1b	63	20	meta	meta	NNP
cord-266948-n7sltd1b	63	21	-	-	HYPH
cord-266948-n7sltd1b	63	22	analysis	analysis	NN
cord-266948-n7sltd1b	63	23	Inhibitors	Inhibitors	NNPS
cord-266948-n7sltd1b	63	24	of	of	IN
cord-266948-n7sltd1b	63	25	the	the	DT
cord-266948-n7sltd1b	63	26	reninangiotensin	reninangiotensin	JJ
cord-266948-n7sltd1b	63	27	-	-	HYPH
cord-266948-n7sltd1b	63	28	aldosterone	aldosterone	NN
cord-266948-n7sltd1b	63	29	system	system	NN
cord-266948-n7sltd1b	63	30	and	and	CC
cord-266948-n7sltd1b	63	31	Covid-19	Covid-19	NNP
cord-266948-n7sltd1b	63	32	Inactivation	Inactivation	NNP
cord-266948-n7sltd1b	63	33	of	of	IN
cord-266948-n7sltd1b	63	34	plateletderived	plateletderived	JJ
cord-266948-n7sltd1b	63	35	TGF	TGF	NNP
cord-266948-n7sltd1b	63	36	-	-	HYPH
cord-266948-n7sltd1b	63	37	β1	β1	NNP
cord-266948-n7sltd1b	63	38	attenuates	attenuate	VBZ
cord-266948-n7sltd1b	63	39	aortic	aortic	JJ
cord-266948-n7sltd1b	63	40	stenosis	stenosis	NN
cord-266948-n7sltd1b	63	41	progression	progression	NN
cord-266948-n7sltd1b	63	42	in	in	IN
cord-266948-n7sltd1b	63	43	a	a	DT
cord-266948-n7sltd1b	63	44	robust	robust	JJ
cord-266948-n7sltd1b	63	45	murine	murine	JJ
cord-266948-n7sltd1b	63	46	model	model	NN
cord-266948-n7sltd1b	64	1	The	the	DT
cord-266948-n7sltd1b	64	2	pathogenicity	pathogenicity	NN
cord-266948-n7sltd1b	64	3	of	of	IN
cord-266948-n7sltd1b	64	4	SARS	SARS	NNP
cord-266948-n7sltd1b	64	5	-	-	HYPH
cord-266948-n7sltd1b	64	6	CoV-2	CoV-2	NNP
cord-266948-n7sltd1b	64	7	in	in	IN
cord-266948-n7sltd1b	64	8	hACE2	hace2	NN
cord-266948-n7sltd1b	64	9	transgenic	transgenic	JJ
cord-266948-n7sltd1b	64	10	mice	mouse	NNS
cord-266948-n7sltd1b	65	1	Acknowledgements	acknowledgement	NNS
cord-266948-n7sltd1b	66	1	The	the	DT
cord-266948-n7sltd1b	66	2	authors	author	NNS
cord-266948-n7sltd1b	66	3	would	would	MD
cord-266948-n7sltd1b	66	4	like	like	VB
cord-266948-n7sltd1b	66	5	to	to	TO
cord-266948-n7sltd1b	66	6	thank	thank	VB
cord-266948-n7sltd1b	66	7	Life	Life	NNP
cord-266948-n7sltd1b	66	8	Science	Science	NNP
cord-266948-n7sltd1b	66	9	Editors	Editors	NNPS
cord-266948-n7sltd1b	66	10	and	and	CC
cord-266948-n7sltd1b	66	11	M	M	NNP
cord-266948-n7sltd1b	66	12	K	K	NNP
cord-266948-n7sltd1b	66	13	Occhipinti	Occhipinti	NNP
cord-266948-n7sltd1b	66	14	for	for	IN
cord-266948-n7sltd1b	66	15	editing	edit	VBG
cord-266948-n7sltd1b	66	16	the	the	DT
cord-266948-n7sltd1b	66	17	manuscript	manuscript	NN
cord-266948-n7sltd1b	66	18	and	and	CC
cord-266948-n7sltd1b	66	19	Dr	Dr	NNP
cord-266948-n7sltd1b	66	20	J	J	NNP
cord-266948-n7sltd1b	66	21	Laurence	Laurence	NNP
cord-266948-n7sltd1b	66	22	,	,	,
cord-266948-n7sltd1b	66	23	MD	MD	NNP
cord-266948-n7sltd1b	66	24	,	,	,
cord-266948-n7sltd1b	66	25	for	for	IN
cord-266948-n7sltd1b	66	26	his	-PRON-	PRP$
cord-266948-n7sltd1b	66	27	critical	critical	JJ
cord-266948-n7sltd1b	66	28	comments	comment	NNS
cord-266948-n7sltd1b	66	29	.	.	.
cord-266948-n7sltd1b	67	1	Contributors	contributor	NNS
cord-266948-n7sltd1b	67	2	JA	JA	NNP
cord-266948-n7sltd1b	67	3	conceive	conceive	VBP
cord-266948-n7sltd1b	67	4	the	the	DT
cord-266948-n7sltd1b	67	5	idea	idea	NN
cord-266948-n7sltd1b	67	6	and	and	CC
cord-266948-n7sltd1b	67	7	wrote	write	VBD
cord-266948-n7sltd1b	67	8	the	the	DT
cord-266948-n7sltd1b	67	9	manuscript	manuscript	NN
cord-266948-n7sltd1b	67	10	.	.	.
cord-266948-n7sltd1b	68	1	Funding	funding	NN
cord-266948-n7sltd1b	69	1	The	the	DT
cord-266948-n7sltd1b	69	2	work	work	NN
cord-266948-n7sltd1b	69	3	of	of	IN
cord-266948-n7sltd1b	69	4	the	the	DT
cord-266948-n7sltd1b	69	5	author	author	NN
cord-266948-n7sltd1b	69	6	herein	herein	RB
cord-266948-n7sltd1b	69	7	is	be	VBZ
cord-266948-n7sltd1b	69	8	supported	support	VBN
cord-266948-n7sltd1b	69	9	by	by	IN
cord-266948-n7sltd1b	69	10	NHLBI	NHLBI	NNP
cord-266948-n7sltd1b	69	11	grant	grant	NN
cord-266948-n7sltd1b	69	12	#	#	NN
cord-266948-n7sltd1b	69	13	HL123605	hl123605	NN
cord-266948-n7sltd1b	69	14	and	and	CC
cord-266948-n7sltd1b	69	15	HL148123	hl148123	NN
cord-266948-n7sltd1b	69	16	(	(	-LRB-
cord-266948-n7sltd1b	69	17	JA	JA	NNP
cord-266948-n7sltd1b	69	18	)	)	-RRB-
cord-266948-n7sltd1b	69	19	and	and	CC
cord-266948-n7sltd1b	70	1	the	the	DT
cord-266948-n7sltd1b	70	2	laboratory	laboratory	NN
cord-266948-n7sltd1b	70	3	of	of	IN
cord-266948-n7sltd1b	70	4	JA	JA	NNP
cord-266948-n7sltd1b	70	5	was	be	VBD
cord-266948-n7sltd1b	70	6	supported	support	VBN
cord-266948-n7sltd1b	70	7	by	by	IN
cord-266948-n7sltd1b	70	8	GM114731	GM114731	NNP
cord-266948-n7sltd1b	70	9	,	,	,
cord-266948-n7sltd1b	70	10	CA213987	CA213987	NNP
cord-266948-n7sltd1b	70	11	,	,	,
cord-266948-n7sltd1b	70	12	OCASCR	OCASCR	NNP
cord-266948-n7sltd1b	70	13	and	and	CC
cord-266948-n7sltd1b	70	14	PHF	PHF	NNP
cord-266948-n7sltd1b	70	15	grants	grant	NNS
cord-266948-n7sltd1b	70	16	.	.	.
cord-266948-n7sltd1b	71	1	Ahamed	Ahamed	NNP
cord-266948-n7sltd1b	71	2	J.	J.	NNP
cord-266948-n7sltd1b	71	3	Open	Open	NNP
cord-266948-n7sltd1b	71	4	Heart	Heart	NNP
cord-266948-n7sltd1b	72	1	2020;7	2020;7	LS
cord-266948-n7sltd1b	72	2	:	:	:
cord-266948-n7sltd1b	73	1	e001355	e001355	NNP
cord-266948-n7sltd1b	73	2	.	.	.
cord-266948-n7sltd1b	74	1	doi:10.1136	doi:10.1136	NNP
cord-266948-n7sltd1b	74	2	/	/	SYM
cord-266948-n7sltd1b	74	3	openhrt-2020	openhrt-2020	NN
cord-266948-n7sltd1b	74	4	-	-	HYPH
cord-266948-n7sltd1b	74	5	001355	001355	CD
cord-266948-n7sltd1b	75	1	Viewpoint	viewpoint	NN
cord-266948-n7sltd1b	75	2	ORCID	ORCID	NNP
cord-266948-n7sltd1b	75	3	iD	iD	NNP
cord-266948-n7sltd1b	76	1	Jasimuddin	Jasimuddin	NNP
cord-266948-n7sltd1b	76	2	Ahamed	Ahamed	NNP
cord-266948-n7sltd1b	76	3	http://	http://	NN
cord-266948-n7sltd1b	76	4	orcid	orcid	JJ
cord-266948-n7sltd1b	76	5	.	.	.
cord-266948-n7sltd1b	77	1	org/	org/	NNP
cord-266948-n7sltd1b	77	2	0000	0000	CD
cord-266948-n7sltd1b	77	3	-	-	HYPH
cord-266948-n7sltd1b	77	4	0001	0001	CD
cord-266948-n7sltd1b	78	1	-6455	-6455	:
cord-266948-n7sltd1b	78	2	-	-	JJ
cord-266948-n7sltd1b	78	3	0296	0296	CD
cord-266948-n7sltd1b	79	1	Competing	compete	VBG
cord-266948-n7sltd1b	79	2	interests	interest	NNS
cord-266948-n7sltd1b	79	3	None	None	NNP
cord-266948-n7sltd1b	79	4	declared	declare	VBD
cord-266948-n7sltd1b	79	5	.	.	.